Your browser doesn't support javascript.
loading
T follicular helper cells in human efferent lymph retain lymphoid characteristics.
Vella, Laura A; Buggert, Marcus; Manne, Sasikanth; Herati, Ramin S; Sayin, Ismail; Kuri-Cervantes, Leticia; Bukh Brody, Irene; O'Boyle, Kaitlin C; Kaprielian, Hagop; Giles, Josephine R; Nguyen, Son; Muselman, Alexander; Antel, Jack P; Bar-Or, Amit; Johnson, Matthew E; Canaday, David H; Naji, Ali; Ganusov, Vitaly V; Laufer, Terri M; Wells, Andrew D; Dori, Yoav; Itkin, Maxim G; Betts, Michael R; Wherry, E John.
Afiliación
  • Vella LA; Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Buggert M; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Manne S; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Herati RS; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Sayin I; Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden.
  • Kuri-Cervantes L; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Bukh Brody I; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • O'Boyle KC; Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kaprielian H; Department of Medicine, Case Western Reserve University and Cleveland Veterans Affairs, Cleveland, Ohio, USA.
  • Giles JR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Nguyen S; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Muselman A; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Antel JP; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Bar-Or A; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Johnson ME; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Canaday DH; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Naji A; Parker Institute for Cancer Immunotherapy at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Ganusov VV; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Laufer TM; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Wells AD; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Dori Y; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Itkin MG; Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
  • Betts MR; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Wherry EJ; Neuroimmunology Unit, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
J Clin Invest ; 129(8): 3185-3200, 2019 07 02.
Article en En | MEDLINE | ID: mdl-31264971
ABSTRACT
T follicular helper cells (Tfh), a subset of CD4+ T cells, provide requisite help to B cells in the germinal centers (GC) of lymphoid tissue. GC Tfh are identified by high expression of the chemokine receptor CXCR5 and the inhibitory molecule PD-1. Although more accessible, blood contains lower frequencies of CXCR5+ and PD-1+ cells that have been termed circulating Tfh (cTfh). However, it remains unclear whether GC Tfh exit lymphoid tissues and populate this cTfh pool. To examine exiting cells, we assessed the phenotype of Tfh present within the major conduit of efferent lymph from lymphoid tissues into blood, the human thoracic duct. Unlike what was found in blood, we consistently identified a CXCR5-bright PD-1-bright (CXCR5BrPD-1Br) Tfh population in thoracic duct lymph (TDL). These CXCR5BrPD-1Br TDL Tfh shared phenotypic and transcriptional similarities with GC Tfh. Moreover, components of the epigenetic profile of GC Tfh could be detected in CXCR5BrPD-1Br TDL Tfh and the transcriptional imprint of this epigenetic signature was enriched in an activated cTfh subset known to contain vaccine-responding cells. Together with data showing shared TCR sequences between the CXCR5BrPD-1Br TDL Tfh and cTfh, these studies identify a population in TDL as a circulatory intermediate connecting the biology of Tfh in blood to Tfh in lymphoid tissue.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conducto Torácico / Linfocitos T Colaboradores-Inductores / Ganglios Linfáticos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Clin Invest Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Conducto Torácico / Linfocitos T Colaboradores-Inductores / Ganglios Linfáticos Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Clin Invest Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos